ENTITY
Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) (600196 CH)

75
Analysis
Health CareChina
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
more
24 Aug 2024 20:58

Henlius (2696 HK): Share Alternative Facilitates the Vote

The share alternative offer was necessary to secure the support of some substantial shareholders and facilitate the vote. At the last close, the...

Logo
457 Views
Share
19 Aug 2024 00:39

Merger Arb Mondays (19 Aug) - China TCM, Henlius, Canvest, CPMC, JTower, Fuji Soft PropertyGuru

This week, the highest gross spreads are HEC Pharma (114.4%), JTower (69.0%), China TCM (11.9%), Canvest (10.4%), Capitol (8.5%), Malaysia Airports...

Logo
271 Views
Share
12 Aug 2024 00:33

Merger Arb Mondays (12 Aug) - China TCM, Canvest, GA Pack, Fuji Soft, Fancl, Descente, Takiron

This week, the highest gross spreads are HEC Pharma (112.5%), China TCM (27.1%), Canvest (11.4%), Malaysia Airports (10.1%), Asia Cement China...

Logo
369 Views
Share
05 Aug 2024 00:32

Merger Arb Mondays (05 Aug) - Henlius, Asia Cement, Canvest, GA Pack, CPMC, A8, Fancl

This week, the highest gross spreads are HEC Pharma (123.7%), China TCM (36.1%), Asia Cement China (11.4%), Canvest (11.4%), Henlius (8.8%),...

Logo
350 Views
Share
bullishArvida
01 Aug 2024 07:00

(Mostly) Asia M&A, July 2024: Canvest, Furukawa, Arvida, Advanced Info, Sermsuk, Thaicom

The average premium for the new transactions announced (or first discussed) in July was ~31%. The average premium YTD is ~44%.

Logo
356 Views
Share
x